Type 2 blood-group H trisaccharide(60797-31-1)
- Name: Type 2 blood-group H trisaccharide
- Synonyms:O-6-Deoxy-alpha-L-galactopyranosyl-(1-2)-O-beta-D-galactopyranosyl-(1-4)-2-(acetylamino)-2-deoxy-D-glucose;Type 2 blood-group H trisaccharide;D-Glucose, O-6-deoxy-α-L-galactopyranosyl-(1→2)-O-β-D-galactopyranosyl-(1→4)-2-(acetylamino)-2-deoxy-;Blood group H antigen triose type 2 grafted on BSA;Blood group H antigen triose type 2 grafted on CRM197;Blood group H antigen triose type 2 grafted on HSA;Blood group H antigen triose type 2 grafted on KLH;Blood group H antigen triose type 2 grafted on OVA
- Molecular Formula:C20H35NO15
- Molecular Weight:529.49
- CAS Registry Number:60797-31-1
- EINECS:
- Melting Point:975.1±65.0 °C(Predicted)
- Water Solubility:
Other Product
- 60758-96-5/4-ethoxy-3-methoxybenzene-1-carbothioamide
- 607696-30-0/2-amino-4-{4-[(4-chlorobenzyl)oxy]-3-methoxyphenyl}-7-methyl-5-oxo-5,6-dihydro-4H-pyrano[3,2-c]pyridine-3-carbonitrile
- 607697-02-9/3-(Methylsulfanyl)-1-[3-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-4-isoquinolinecarbonitrile
- 607697-25-6/6-(furan-2-yl)-2-(methylsulfanyl)-4-(trifluoromethyl)pyridine-3-carbonitrile
- 607702-85-2/(E)-4-((5-(4-bromophenyl)furan-2-yl)methylene)-5-methyl-2,4-dihydro-3H-pyrazol-3-one
- 607702-88-5/(E)-4-((5-(4-chlorophenyl)furan-2-yl)methylene)-5-methyl-2,4-dihydro-3H-pyrazol-3-one
- 60770-50-5/3(2H)-Benzofuranone, 5-fluoro-2-methyl-
- 607722-95-2/607722-95-2
- 607725-01-9/ethyl 3-[(aminocarbonothioyl)hydrazono]-2-methylbutanoate
- 607737-07-5/New crosslinking agent
- 607738-99-8/Pyrrolo[2,1-f][1,2,4]triazine-6-carboxylic acid, 4-chloro-5-methyl-
- 607744-75-2/2λ5,4λ5,6λ5-1,3,5,2,4,6-Triazatriphosphorine, 2,2,4,4,6-pentafluoro-6-(2,2,2-trifluoroethoxy)-
- 60778-00-9/Isorhamnetin 3-O-β-D-glucose-7-O-β-D-gentiobioside
- 60778-01-0/4H-1-Benzopyran-4-one, 7-[(6-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]-3-(β-D-glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-
- 60780-86-1/4-methyl-6-nitropyridine-3-carboxylic acid
- 60780-91-8/2-Pyridinecarboxylic acid, 4-methyl-6-nitro-
- 60783-95-1/5-Bromo-2-(isopentyloxy)benzoic acid
- 60788-12-7/1H-Imidazole, 1-octyl-, hydrochloride (1:1)
- 60788-57-0/3-Hydroxy-1-phenylcyclobutane-1-carbonitrile
- 60797-31-1/Type 2 blood-group H trisaccharide
- 60798-89-2/5-(1-adamantyl)-2H-tetrazole
- 60803-15-8/Cyclohepta[a]cyclopenta[f]naphthalene-1,7-diol, 1,2,3,3a,3b,4,5,5a,6,7,8,9,10,11,12,12a-hexadecahydro-12a-methyl-, diacetate, (1S,3aS,3bS,5aR,7S,12aS)- (9CI)
- 60803-16-9/Androstane-3,17,19-triol, 19-acetate, (3β,5α,17β)- (9CI)
- 60803-18-1/Benzenesulfonohydrazonic acid, N-[(4-methylphenyl)sulfonyl]-4-methyl- (9CI)
- 60803-19-2/Tricyclo[3.3.0.02,6]octane-3-carboxaldehyde, 4-oxo- (9CI)
- 60803-21-6/Tricyclo[3.3.0.02,6]octanone, 4-diazo- (9CI)
- 60803-22-7/Tricyclo[3.3.0.02,6]octanone, 4-(dimethylamino)- (9CI)
- 60803-23-8/Tricyclo[3.2.0.02,6]heptane-7-carboxamide, N,N-dimethyl- (9CI)
- 60803-31-8/[1,1'-Biphenyl]-4,4'-diol, 3,3'-dibromo-5,5'-bis(1,1-dimethylethyl)-
- 60806-40-8/Poly[oxy(1,4-dioxo-1,4-butanediyl)oxymethylene-1,4-cyclohexanediylmethylene]